Cargando…

A review of the therapeutic management of ulcerative colitis

Ulcerative colitis (UC) is a chronic relapsing and remitting gastrointestinal disorder of uncertain aetiology. The last two decades have seen an expansion in the therapeutic arsenal used to treat UC. This has resulted in improved clinical remission and response rates. Nonetheless, staples in our cur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aslam, Nasar, Lo, Sheng Wei, Sikafi, Rafid, Barnes, Tom, Segal, Jonathan, Smith, Philip J, Limdi, Jimmy K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720837/ https://www.ncbi.nlm.nih.gov/pubmed/36478780 http://dx.doi.org/10.1177/17562848221138160

Ejemplares similares

A review of the therapeutic management of Crohn’s disease
por: Kumar, Aditi, et al.
Publicado: (2022)

Further Validation of the Crohn’s and Ulcerative Colitis Questionnaire-32 (CUCQ-32) to Measure the Quality of Life in Patients Treated with Biologics Therapy
por: Alrubaiy, Laith, et al.
Publicado: (2022)

Tofacitinib and newer JAK inhibitors in inflammatory bowel disease—where we are and where we are going
por: Liu, Eleanor, et al.
Publicado: (2022)

The LUCID study: living with ulcerative colitis; identifying the socioeconomic burden in Europe
por: Ruiz-Casas, Leonardo, et al.
Publicado: (2021)

Correction to: The LUCID study: living with ulcerative colitis; identifying the socioeconomic burden in Europe
por: Ruiz-Casas, Leonardo, et al.
Publicado: (2021)

Management of ulcerative colitis
por: Fell, John M, et al.
Publicado: (2016)

Prevalence of ‘pouch failure’ of the ileoanal pouch in ulcerative colitis: a systematic review and meta-analysis
por: Alsafi, Zaid, et al.
Publicado: (2021)

The Microbiome as a Therapy in Pouchitis and Ulcerative Colitis
por: LeBlanc, Jean-Frédéric, et al.
Publicado: (2021)

Disease clearance in ulcerative colitis: Setting the therapeutic goals for future in the treatment of ulcerative colitis
por: Ramos, Laura, et al.
Publicado: (2023)

Vedolizumab in the treatment of inflammatory bowel disease: evolving paradigms
por: Crooks, Benjamin, et al.
Publicado: (2020)

Factors associated with long‐term healthcare expense and steroid exposure in patients admitted with acute severe ulcerative colitis
por: Gilmore, Robert, et al.
Publicado: (2023)

Penile Pyoderma Gangrenosum in Pediatric Ulcerative Colitis
por: Thomas, Michael J., et al.
Publicado: (2023)

Biomarkers in the management of ulcerative colitis: a brief review
por: Masoodi, Ibrahim, et al.
Publicado: (2011)

Pediatric Ulcerative Colitis: The Therapeutic Road to Infliximab
por: Puthoor, Pamela R., et al.
Publicado: (2013)

Therapeutic Potential of Proanthocyanidins in Ulcerative Colitis in Remission
por: Głąbska, Dominika, et al.
Publicado: (2020)

Gaseous metabolites as therapeutic targets in ulcerative colitis
por: Yao, Chu K, et al.
Publicado: (2023)

Management of a large percutaneous endoscopic gastrostomy tube-associated gastric ulcer with endoscopic suturing
por: Norton, Benjamin, et al.
Publicado: (2023)

Leukocyte Apheresis in the Management of Ulcerative Colitis
por: Helmy, Ahmed, et al.
Publicado: (2009)

Management of elderly ulcerative colitis in Japan
por: Higashiyama, Masaaki, et al.
Publicado: (2019)

Managing ulcerative colitis after surgery
por: Calvino-Suarez, Cristina, et al.
Publicado: (2023)

Histological evaluation in ulcerative colitis
por: DeRoche, Tom C., et al.
Publicado: (2014)

Optimal Management of Acute Severe Ulcerative Colitis (ASUC): Challenges and Solutions
por: Holvoet, Tom, et al.
Publicado: (2021)

Natural compounds as safe therapeutic options for ulcerative colitis
por: Gupta, Mukta, et al.
Publicado: (2022)

Disease clearance in ulcerative colitis: Is the ultimate therapeutic target?
por: D’Amico, Ferdinando, et al.
Publicado: (2023)

Crohn's disease and ulcerative colitis Surgical management
por: Wilkinson, A J
Publicado: (1996)

Optimal management of steroid-dependent ulcerative colitis
por: Khan, Hafiz M Waqas, et al.
Publicado: (2015)

Current new challenges in the management of ulcerative colitis
por: Fukuda, Tomohiro, et al.
Publicado: (2019)

Second Korean guidelines for the management of ulcerative colitis
por: Choi, Chang Hwan, et al.
Publicado: (2017)

Correction to: Management of elderly ulcerative colitis in Japan
por: Higashiyama, Masaaki, et al.
Publicado: (2019)

ULCERATIVE COLITIS
Publicado: (1969)

Optimizing individualized management of patients with ulcerative colitis: Identification of risk factors predicting ulcerative colitis-associated neoplasia
por: Jiang, Wenyu, et al.
Publicado: (2023)

Ozanimod: A Review in Ulcerative Colitis
por: Paik, Julia
Publicado: (2022)

Effectiveness of sigmoidoscopy for assessing ulcerative colitis disease activity and therapeutic response
por: Lin, Wei-Chen, et al.
Publicado: (2019)

Genetics and Therapeutics in Pediatric Ulcerative Colitis: the Past, Present and Future
por: Sifuentes-Dominguez, Luis, et al.
Publicado: (2016)

Alicaforsen: An Emerging Therapeutic Agent for Ulcerative Colitis and Refractory Pouchitis
por: Hosten, Terron Anthony, et al.
Publicado: (2014)

Inhibiting Ferroptosis: A Novel Approach for Ulcerative Colitis Therapeutics
por: Huang, Jinke, et al.
Publicado: (2022)

Therapeutic Drug Monitoring of Infliximab in Acute Severe Ulcerative Colitis
por: Gordon, Benjamin L., et al.
Publicado: (2023)

Mucosal Transcriptomics Implicates Under Expression of BRINP3 in the Pathogenesis of Ulcerative Colitis
por: Smith, Philip J., et al.
Publicado: (2014)

Tracheobronchitis in ulcerative colitis: a case report of therapeutic response with infliximab and review of the literature
por: Horgan, Lisa, et al.
Publicado: (2019)

Therapeutic Effect of Mesenchymal Stem Cells in Ulcerative Colitis: A Review on Achievements and Challenges
por: Hosseini-Asl, Seyed-Kazem, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dig2qvg8970jdqo2862bj38te0